Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Breast Neoplasms and E2F1[original query] |
|---|
| A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer. Oncotarget 2016 Sep 7 (42): 68012-68022. Malorni Luca, Piazza Silvano, Ciani Yari, Guarducci Cristina, Bonechi Martina, Biagioni Chiara, Hart Christopher D, Verardo Roberto, Di Leo Angelo, Migliaccio Ilen |
| Comprehensive molecular biomarker identification in breast cancer brain metastases. Journal of translational medicine 2017 12 15 (1): 269. Schulten Hans-Juergen, Bangash Mohammed, Karim Sajjad, Dallol Ashraf, Hussein Deema, Merdad Adnan, Al-Thoubaity Fatma K, Al-Maghrabi Jaudah, Jamal Awatif, Al-Ghamdi Fahad, Choudhry Hani, Baeesa Saleh S, Chaudhary Adeel G, Al-Qahtani Mohammed |
| Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility. Nature communications 2021 9 12 (1): 5318. Wen Wanqing, Chen Zhishan, Bao Jiandong, Long Quan, Shu Xiao-Ou, Zheng Wei, Guo Xing |
| E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women. Molecular medicine (Cambridge, Mass.) 2021 03 27 (1): 26. Rocca Maria Santa, Benna Clara, Goldin Elena, Di Nisio Andrea, De Toni Luca, Cosci Ilaria, Marchet Alberto, Nitti Donato, Foresta Car |
- Page last reviewed:Feb 1, 2024
- Content source: